Lineage Cell Therapeutics Earnings
NYSE: LCTXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
0.994-0.036 (-3.50%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Thu, Nov 5, 2026
Fiscal period
Sep/2026
EPS estimate
$-0.02
Lineage Cell Therapeutics earnings summary
Lineage Cell Therapeutics is scheduled to report Sep/2026 earnings on Nov 5, 2026, with analysts expecting EPS of $-0.02.
Summary generated from market data by MetaCap's automated system. Methodology